Renal safety profile of STB in virologically suppressed subjects from two randomized phase 3b switch trials.

Reeves, Iain; Fisher, Martin; Kegg, Stephen; Arribas, Jose; Dau, Lauren; Garner, Will; Walker, Ivan; Nguyen, Thai

Reeves, Iain; Fisher, Martin; Kegg, Stephen; Arribas, Jose; Dau, Lauren; Garner, Will; Walker, Ivan; Nguyen, Thai.

Afiliación

Reeves I; Homerton Sexual Health Services, Homerton University Hospital, London, UK.
Fisher M; Brighton and Sussex University Hospital NHS Trust, Department of HIV, Brighton, UK.
Kegg S; The Trafalgar Clinic, Queen Elizabeth Hospital, London, UK.
Arribas J; Consulta de Medicina Interna II, Hospital Universitario La Paz, Madrid, Spain.
Dau L; HIV Medical Affairs, Gilead Sciences, Foster City, USA.
Garner W; Department of Biostatistics, Gilead Sciences, Foster City, USA.
Walker I; HIV Medical Affairs, Gilead Sciences, Foster City, USA.
Nguyen T; HIV Medical Affairs, Gilead Sciences, Foster City, USA.

J Int AIDS Soc ; 17(4 Suppl 3): 19807, 2014.

Article en En | MEDLINE | ID: mdl-25397551

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Int AIDS Soc Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google